• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥肝细胞癌的性别特征:一项多机构合作研究

Characteristics of Hepatocellular Carcinoma by Sex in Mexico: A Multi-Institutional Collaboration.

作者信息

Melchor-Ruan Javier, Santiago-Ruiz Luis, Murillo-Ortiz Blanca Olivia, Rivera-Rivera Samuel, Leal-Herrera Yelda A, Suárez-García David, Remes-Troche José María, Grube Peter, Martínez-Mier Gustavo, Ruiz-García Erika, Ramos-Mayo Alan, Velarde-Ruiz-Velasco José Antonio, Gamboa-Gutierrez Ricardo, Ordoñez-Escalante Karla Gabriela, Cisneros-Garza Laura Esthela, Leal-Leyte Pilar, Sepúlveda-Delgado Jesús, González-Huezo María Saraí, Arvizu-Castillo Ricardo, Urías-Rocha Jorge, Flores-de-la-Torre Celia Beatriz, Carrillo-Mendoza Leonardo Manuel, Gámez-Del-Castillo Juan Manuel, Lajous Martín, Monge Adriana, Zamora-Valdés Daniel

机构信息

Departamento de Gastroenterología, Instituto Nacional de Cancerología, Ciudad de México 14080, Mexico.

Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.

出版信息

Diseases. 2024 Oct 21;12(10):262. doi: 10.3390/diseases12100262.

DOI:10.3390/diseases12100262
PMID:39452505
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11508022/
Abstract

Liver cancer is the fourth leading cause of cancer-related death worldwide. In Mexico, there is a high burden of liver cancer mortality in rural states, affecting both women and men equally. Thus, we aimed to describe the demographic and clinical characteristics of hepatocellular cancer (HCC) by sex in Mexico. Demographic and clinical information was extracted retrospectively from the medical records of patients with HCC initially treated (2015-2022) at institutions participating in a national survey across the country. The male-to-female ratio was calculated at the national and regional levels, and the results were stratified by sex. Among 697 HCC patients, the age at diagnosis was 65.4 ± 11.9 years and 20% were diagnosed at ≥75 years. The male-to-female ratio was 1.4:1, ranging from 1:1 in the northwestern and southwestern regions, to 2.1:1 in the western region. The proportion of cirrhosis was similar between the sexes; however, the etiology of cirrhosis differed: cryptogenic cirrhosis was higher in women and alcohol consumption was higher in men. Men had a higher proportion of advanced HCC, poor/undifferentiated tumors, and ≥4 nodules than women. HCC in the Mexican population affects both men and women at a 1.4:1 male-to-female ratio. This unique proportion by sex could be explained by the differences in the prevalence of risk factors across our heterogeneous country.

摘要

肝癌是全球癌症相关死亡的第四大主要原因。在墨西哥,农村各州肝癌死亡率负担沉重,对男性和女性的影响相当。因此,我们旨在描述墨西哥肝细胞癌(HCC)按性别划分的人口统计学和临床特征。人口统计学和临床信息是从参与全国性调查的各机构中最初接受治疗(2015 - 2022年)的HCC患者的病历中回顾性提取的。在国家和地区层面计算男女比例,并按性别对结果进行分层。在697例HCC患者中,诊断时的年龄为65.4±11.9岁,20%的患者在75岁及以上被诊断。男女比例为1.4:1,从西北部和西南部地区的1:1到西部地区的2.1:1不等。肝硬化的比例在两性之间相似;然而,肝硬化的病因不同:女性隐源性肝硬化比例较高,男性酒精性肝硬化比例较高。男性晚期HCC、低分化/未分化肿瘤以及结节数≥4个的比例高于女性。墨西哥人群中的HCC以1.4:1的男女比例影响男性和女性。这种独特的性别比例可能是由我们这个多元化国家危险因素患病率的差异所解释的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ba/11508022/d1e915d55418/diseases-12-00262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ba/11508022/fb9f9fe15143/diseases-12-00262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ba/11508022/d1e915d55418/diseases-12-00262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ba/11508022/fb9f9fe15143/diseases-12-00262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ba/11508022/d1e915d55418/diseases-12-00262-g002.jpg

相似文献

1
Characteristics of Hepatocellular Carcinoma by Sex in Mexico: A Multi-Institutional Collaboration.墨西哥肝细胞癌的性别特征:一项多机构合作研究
Diseases. 2024 Oct 21;12(10):262. doi: 10.3390/diseases12100262.
2
Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States.性别因素不容忽视:来自美国一项大型多中心研究的女性肝细胞癌特征。
Am J Gastroenterol. 2020 Sep;115(9):1486-1495. doi: 10.14309/ajg.0000000000000643.
3
Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study.酒精性和隐源性肝硬化中肝细胞癌的临床特征与转归:一项前瞻性研究
Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):401-5. doi: 10.1016/s1499-3872(15)60343-5.
4
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort study.肝硬化中肝细胞癌的风险因病因、年龄和性别而异:一项瑞典全国基于人群的队列研究。
United European Gastroenterol J. 2022 Jun;10(5):465-476. doi: 10.1002/ueg2.12238. Epub 2022 May 1.
5
Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico.发展中国家肝硬化病因的趋势:从感染性疾病向代谢性疾病的转变。来自墨西哥中部一个多中心队列的报告。
Lancet Reg Health Am. 2021 Dec 21;7:100151. doi: 10.1016/j.lana.2021.100151. eCollection 2022 Mar.
6
Study of liver cirrhosis over ten consecutive years in Southern China.中国南方地区连续十年肝硬化研究。
World J Gastroenterol. 2014 Oct 7;20(37):13546-55. doi: 10.3748/wjg.v20.i37.13546.
7
Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.按年龄、性别和肝脏疾病状况分层的肝细胞癌风险因素:韩国一项前瞻性队列研究。
Cancer. 2018 Jul 1;124(13):2748-2757. doi: 10.1002/cncr.31406. Epub 2018 Apr 18.
8
Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study.印度伴有和不伴有肝硬化背景的肝细胞癌患者的病因分数:一项多中心研究。
Hepatol Int. 2023 Jun;17(3):745-752. doi: 10.1007/s12072-023-10498-w. Epub 2023 Mar 20.
9
Mexican consensus on the diagnosis and management of hepatocellular carcinoma.墨西哥肝细胞癌诊断与管理共识
Rev Gastroenterol Mex. 2014 Oct-Dec;79(4):250-62. doi: 10.1016/j.rgmx.2014.09.004. Epub 2014 Dec 6.
10
Geographic variation within the United States in the incidence of hepatocellular carcinoma.美国肝细胞癌发病率的地理差异。
J Clin Epidemiol. 2003 May;56(5):487-93. doi: 10.1016/s0895-4356(02)00605-4.

本文引用的文献

1
Aflatoxin exposure in adults in southern and eastern Mexico in 2018: A descriptive study.2018 年墨西哥南部和东部成年人黄曲霉毒素暴露情况:一项描述性研究。
Int J Hyg Environ Health. 2023 Aug;253:114249. doi: 10.1016/j.ijheh.2023.114249. Epub 2023 Sep 5.
2
Prevalence of hepatitis C in the adult Mexican population: National Survey of Health and Nutrition 2018.墨西哥成年人口中丙型肝炎的患病率:2018年全国健康与营养调查
Lancet Reg Health Am. 2021 Dec 31;8:100165. doi: 10.1016/j.lana.2021.100165. eCollection 2022 Apr.
3
Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico.
发展中国家肝硬化病因的趋势:从感染性疾病向代谢性疾病的转变。来自墨西哥中部一个多中心队列的报告。
Lancet Reg Health Am. 2021 Dec 21;7:100151. doi: 10.1016/j.lana.2021.100151. eCollection 2022 Mar.
4
Gender Differences in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的性别差异
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S19-S25. doi: 10.5005/jp-journals-10018-1370.
5
Cancer Incidence in Merida, Mexico 2015-2018: First Report from the Population-based Cancer Registry.墨西哥梅里达2015 - 2018年癌症发病率:基于人群的癌症登记处的首份报告。
Arch Med Res. 2022 Dec;53(8):859-866. doi: 10.1016/j.arcmed.2022.11.015. Epub 2022 Dec 1.
6
Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network.南美洲肝细胞癌流行病学的变化:来自南美肝脏研究网络的报告。
Ann Hepatol. 2023 Mar-Apr;28(2):100876. doi: 10.1016/j.aohep.2022.100876. Epub 2022 Nov 15.
7
Global burden of primary liver cancer in 2020 and predictions to 2040.2020 年全球原发性肝癌负担及 2040 年预测。
J Hepatol. 2022 Dec;77(6):1598-1606. doi: 10.1016/j.jhep.2022.08.021. Epub 2022 Oct 5.
8
Liver cancer mortality in Mexico: trend analysis from 1998 to 2018.墨西哥肝癌死亡率:1998 年至 2018 年的趋势分析。
Salud Publica Mex. 2022 Feb 25;64(1):14-25. doi: 10.21149/12518.
9
Hepatitis B infection in Mexican adults: Results of a nationally representative survey.墨西哥成年人乙型肝炎感染:一项全国代表性调查的结果。
Ann Hepatol. 2022 Jan;27 Suppl 1:100583. doi: 10.1016/j.aohep.2021.100583. Epub 2021 Nov 19.
10
[Not Available].[无可用内容]。
Salud Publica Mex. 2021 May 3;63(3 May-Jun):444-451. doi: 10.21149/12580.